Bifido and Carbamazepine drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Bifido (bifidobacteria) and Carbamazepine (carbamazepine). Common drug interactions include arthropathy among females and anaemia among males.

The phase IV clinical study analyzes what interactions people have when they take Bifido and Carbamazepine. It is created by eHealthMe based on reports of 70 people who take the same drugs from the FDA, and is updated regularly.

What is Bifido?

Bifido has active ingredients of bifidobacteria. eHealthMe is studying from 5,030 Bifido users. Check the latest studies of Bifido.

What is Carbamazepine?

Carbamazepine has active ingredients of carbamazepine. It is often used in epilepsy. eHealthMe is studying from 44,628 Carbamazepine users. Check the latest studies of Carbamazepine.



On Jul, 28, 2026

70 people who take Bifido and Carbamazepine together, and have interactions are studied.

Bifido and Carbamazepine drug interactions.

What are the common drug interactions of Bifido and Carbamazepine, by gender? *:

female:

  1. Arthropathy
  2. Abdominal discomfort
  3. Lower respiratory tract infection
  4. Drug abuse
  5. Obesity (having too much body fat)
  6. Overdose
  7. Knee arthroplasty
  8. Peripheral swelling
  9. Abdominal pain upper
  10. Arterial occlusive disease (slow process through which arteries throughout the body become progressively narrowed and eventually completely blocked)

male:

  1. Anaemia (lack of blood)
  2. Confusional state
  3. Diarrhoea
  4. Hyperlipidaemia (presence of excess lipids in the blood)
  5. Hypoglycaemia (deficiency of glucose in the bloodstream)
  6. Hypoxia (low oxygen in tissues)
  7. Insomnia (sleeplessness)
  8. Platelet count decreased
  9. Sepsis (a severe blood infection that can lead to organ failure and death)

What are the common drug interactions of Bifido and Carbamazepine, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

  1. Glossoptosis
  2. Respiratory depression (respiration has a rate below 12 breaths)
  3. Secretion discharge

10-19:

  1. Hepatitis toxic

20-29:

n/a

30-39:

n/a

40-49:

  1. Diarrhoea
  2. Hyperlipidaemia (presence of excess lipids in the blood)
  3. Insomnia (sleeplessness)

50-59:

  1. Abdominal pain upper
  2. Arterial occlusive disease (slow process through which arteries throughout the body become progressively narrowed and eventually completely blocked)
  3. Arthralgia (joint pain)
  4. Blood pressure fluctuation
  5. Chest pain
  6. Coronary artery disease (plaque building up along the inner walls of the arteries of the heart, which narrows the arteries and restricts blood flow to the heart)
  7. Diarrhoea
  8. Dizziness
  9. Ear disorder
  10. Eye disorder

60+:

  1. Rash
  2. Arthropathy
  3. Hypoglycaemia (deficiency of glucose in the bloodstream)
  4. Hypoxia (low oxygen in tissues)
  5. Platelet count decreased
  6. Sepsis (a severe blood infection that can lead to organ failure and death)
  7. Abdominal discomfort
  8. Lower respiratory tract infection
  9. Drug abuse
  10. Obesity (having too much body fat)

What are the existing conditions these people have? *

  1. Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 57 people, 81.43%
  2. Empty Sella Syndrome (pituitary gland shrinks or becomes flattened): 57 people, 81.43%
  3. Depression: 57 people, 81.43%
  4. Abdominal Discomfort: 57 people, 81.43%
  5. Pituitary Tumor: 55 people, 78.57%
  6. Lower Respiratory Tract Infection: 5 people, 7.14%
  7. Gastric Disorder (disease of stomach): 4 people, 5.71%

* Approximation only. Some reports may have incomplete information.

Do you take Bifido and Carbamazepine?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Bifido and Carbamazepine:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Bifido:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Carbamazepine:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Bifido and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Carbamazepine and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies


How the study uses the data?

The study uses data from the FDA. It is based on bifidobacteria and carbamazepine (the active ingredients of Bifido and Carbamazepine, respectively), and Bifido and Carbamazepine (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: